2018
DOI: 10.1016/j.cardfail.2018.09.010
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Oral Supplementation With Nitrate-Rich Beetroot Juice in Patients With Pulmonary Arterial Hypertension—Results From BEET-PAH, an Exploratory Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 24 publications
(22 citation statements)
references
References 61 publications
0
22
0
Order By: Relevance
“…In a pilot crossover study in 15 patients with PAH, randomized to two 7-day treatment periods (16 mmol/day nitrate vs. placebo), ingestion of a fixed dose of dietary nitrate was associated with increases in exhaled •NO and plasma and salivary NOx and was not associated with any adverse systemic hemodynamic changes. There were no significant changes in pulmonary hemodynamic parameters assessed by echocardiography or cardiopulmonary exercise testing, or of function tests, such as the 6-minute walk test, although there were trends for improvements in right ventricular function and peak power per liter oxygen consumed, particularly in those patients in whom plasma nitrite flux was .30% postnitrate ingestion (Henrohn et al, 2018). Although these data are encouraging, it remains for larger, adequately powered trials to determine whether inorganic nitrate supplementation has benefit in PAH, with or without other drugs that modulate the •NO-GC-1-cGMP system.…”
Section: Nitrite and Nitrate In The Respiratory Systemmentioning
confidence: 83%
“…In a pilot crossover study in 15 patients with PAH, randomized to two 7-day treatment periods (16 mmol/day nitrate vs. placebo), ingestion of a fixed dose of dietary nitrate was associated with increases in exhaled •NO and plasma and salivary NOx and was not associated with any adverse systemic hemodynamic changes. There were no significant changes in pulmonary hemodynamic parameters assessed by echocardiography or cardiopulmonary exercise testing, or of function tests, such as the 6-minute walk test, although there were trends for improvements in right ventricular function and peak power per liter oxygen consumed, particularly in those patients in whom plasma nitrite flux was .30% postnitrate ingestion (Henrohn et al, 2018). Although these data are encouraging, it remains for larger, adequately powered trials to determine whether inorganic nitrate supplementation has benefit in PAH, with or without other drugs that modulate the •NO-GC-1-cGMP system.…”
Section: Nitrite and Nitrate In The Respiratory Systemmentioning
confidence: 83%
“…Other effects of the NO pathway demonstrated by clinical studies are enhancement of blood flow and inhibition of platelet aggregation, therefore possibly protecting BRJ-consumers against cardiovascular disease [13,14]. Additionally, studies have suggested that the NO pathway may be a therapeutic target in patients with pulmonary arterial hypertension [15].…”
Section: Discussionmentioning
confidence: 99%
“…7 The immediate effects of the multi-component formula were rather surprising, as dietary nitrate requires at least an hour to show any known biological effects in humans, with the peak effect usually reported after 180 minutes. [4][5][6] In addition, this nitrate-based nutritional formula appears to be comparable to conventional therapy in treating low SpO 2 caused by COVID-19. The increase in oxygen concentrations seen in patients with COVID-19 on oxygen therapy (1-6 L/ minute) was approximately 4% with each liter of O 2 per minute, 8 which is similar to findings reported in our trial (mean SpO 2 increase ¼ 3.6%).…”
mentioning
confidence: 89%